Cancer Cell Line Encyclopedia (Genentech, Nat biotech 2014)

Summary

Cancer Cell Line Encyclopedia (Genentech, Nat biotech 2014) is a study catalogued by cBioPortal DataHub under the cancer-type code mixed. EvidenceHelix groups it with multiple or not classified from the title studies.

Study description

Single-nucleotide polymorphism (SNP) array analysis and RNA sequencing and of 675 mixed human cancer cell lines from the Cancer Cell Line Encyclopedia.

Text as published in the source's study metadata.

Citation & PubMed

Klijn, Christiaan et al. Nature biotechnology 2014

Linked PubMed records: PMID 25485619

Source & licence

Metadata from cBioPortal DataHub at e1b75cd25b, available under the ODC Open Database License (ODbL) 1.0. See the Source metadata tab for every field.

Source metadata

Study identifier

ccle_genentech_2014

Short name

CCLE (Genentech 2014)

Source cancer-type code

mixed

Reference genome

not given

Source access groups

not given

Original study

View on cBioPortal

Metadata file

meta_study.txt at e1b75cd25b

Database licence

ODC Open Database License (ODbL) 1.0

Study-level metadata only (title, description, cancer-type code, citation, PubMed ids). No patient, sample, mutation or clinical data, and no publication full text, is included. Individual studies may carry their own terms; follow each study's source links before reusing its data.

Citations

Klijn, Christiaan et al. Nature biotechnology 2014

• PubMed record 25485619 ↗

Citation counts are not part of the source metadata and are not shown.

Related studies

• Cancer Cell Line Encyclopedia (Broad, 2019)

  Cancer Cell Line Encyclopedia from the Broad Institute and Novartis, updated 2019. Data downloaded from the Broad CCLE Portal (https://portals.broadinstitute.org/ccle/data). For more info about the proteomics data, se…

  Multiple or not classified from the titleOther published and consortium studiesSource code mixedPubMed 2

• Cancer Cell Line Encyclopedia (Broad, Nat Rev Cancer 2025)

  Whole genome and whole exome sequencing of 1,981 pancancer samples from the Cancer Cell Line Encyclopedia (CCLE). CCLE from Broad Institute and Novartis, 2025 (25Q3) update. Data downloaded from the Depmap Portal (htt…

  Multiple or not classified from the titleOther published and consortium studiesSource code mixedPubMed 1

• China Pan-cancer (OrigiMed, Nature 2022)

  Landscape of genomic alterations in 10,194 solid tumors from the Chinese population

  Multiple or not classified from the titleOther published and consortium studiesSource code mixedPubMed 1

• Metastatic Solid Cancers (UMich, Nature 2017)

  Whole-exome and -transcriptome sequencing of 500 adult patients with metastatic solid tumor/primary normal pairs of diverse lineage and biopsy site.

  Multiple or not classified from the titleOther published and consortium studiesSource code mixedPubMed 1

• MSS Mixed Solid Tumors (Broad/Dana-Farber, Nat Genet 2018)

  Whole exome sequencing of tumor/normal pairs and corresponding clinical outcomes from patients treated with immune checkpoint inhibitors across multiple cancer types including melanoma, non-small cell lung cancer, hea…

  Multiple or not classified from the titleOther published and consortium studiesSource code mixedPubMed 1

• NCI-60 Cell Lines (NCI, Cancer Res 2012)

  Whole-exome sequencing of 67 samples by NCI-60 cell line project; raw data at CellMiner (http://discover.nci.nih.gov/cellminer/loadDownload.do).

  Multiple or not classified from the titleOther published and consortium studiesSource code mixedPubMed 1

• Pan-cancer Analysis of Advanced and Metastatic Tumors (BCGSC, Nature Cancer 2020)

  Whole-genome and transcriptome sequencing of 570 advanced and metastatic cancers and their matched normals.

  Multiple or not classified from the titleOther published and consortium studiesSource code mixedPubMed 1

• Pediatric European MAPPYACTS Trial (Gustave Roussy, Cancer Discov 2022)

  Whole-exome sequencing of 674 pediatric matched normal samples on multiple pathologies driven on mappyacts program and somatic mutation data for 484 single nucleotide alterations reported as potentially actionable, se…

  Multiple or not classified from the titleOther published and consortium studiesSource code mixedPubMed 1

Your notes

Notes and highlights stay in this browser only; they are not sent to EvidenceHelix.